FHA
IRWD icon

First Horizon Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Horizon Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-84
Closed -$809 – 2414
2023
Q3 		$809 Sell
84
-338
-80% -$3.31K ﹤0.01% 2257
2023
Q2 		$4.49K Hold
422
– – ﹤0.01% 1826
2023
Q1 		$4.44K Buy
422
+338
+402% +$3.79K ﹤0.01% 1846
2022
Q4 		$1.04K Hold
84
– – ﹤0.01% 2229
2022
Q3 		$1K Buy
+84
New +$952 ﹤0.01% 2137
2021
Q4 		– Sell
-12
Closed – – 2341
2021
Q3 		$0 Buy
+12
New +$155 ﹤0.01% 2353
2019
Q2 		– Sell
-127
Closed -$1K – 1594
2019
Q1 		$1K Buy
+127
New +$1.42K ﹤0.01% 1494

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

First Horizon Advisors's IRWD Position: Q4 2023 in Review

First Horizon Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2023, closing a stake of 84 shares — an estimated $809 sold.

First Horizon Advisors first reported a position in IRWD in Q1 2019 and held it in 7 quarters. The position peaked at $4.49K in Q2 2023. 251 funds tracked by Wall St. Rank hold IRWD as of Q4 2023.

  • First Horizon Advisors reported no remaining Ironwood Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • First Horizon Advisors sold 84 Ironwood Pharmaceuticals shares in Q4 2023, an estimated $809.
  • First Horizon Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2019 and held it in 7 quarters.
  • First Horizon Advisors's Ironwood Pharmaceuticals position peaked at $4.49K in Q2 2023.
  • 251 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2023.

Based on First Horizon Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.